TABLE 3.
IC025>0 | Ipilimumab | Tremelimumab | Nivolumab | Pembrolizumab | Cemiplimab | Atezolizumab | Avelumab | Durvalumab | Ipilimumab + Nivolumab | Tremelimumab + Durvalumab |
---|---|---|---|---|---|---|---|---|---|---|
Atrioventricular block complete | — | — | 1.17 | 2.00 | — | 0.73 | — | 0.29 | 1.09 | — |
Bundle branch block right | — | — | −1.57 | −1.67 | — | — | — | — | −0.02 | — |
Atrioventricular block | — | — | 0.50 | 0.18 | — | −1.49 | — | — | 0.90 | — |
Bundle branch block left | — | — | — | −1.16 | — | −0.63 | — | — | −0.89 | — |
Arrhythmia | — | — | −0.33 | −0.75 | −1.03 | −2.47 | — | −2.70 | −1.58 | — |
Bradycardia | — | — | −1.46 | −1.70 | — | −1.95 | 0.51 | −2.96 | −3.06 | — |
Tachycardia | −2.18 | 0.48 | −0.89 | −0.45 | — | −0.83 | −1.15 | −0.58 | −0.61 | — |
Atrial fibrillation | −0.66 | — | 0.19 | 0.12 | — | 0.80 | −0.51 | 0.36 | 0.78 | −2.80 |
Sinus tachycardia | — | — | −0.26 | −0.61 | — | 0.14 | — | −1.66 | 1.76 | — |
Atrial flutter | — | — | 0.62 | −0.44 | — | 0.53 | — | — | 0.24 | 1.35 |
Sinus node dysfunction | — | — | 0.71 | −1.84 | — | −0.90 | — | — | — | — |
Supraventricular tachycardia | — | — | 0.43 | 0.43 | — | 1.36 | — | −1.17 | 0.42 | — |
Cardiac arrest | −1.38 | — | −0.35 | −1.03 | — | −0.95 | 0.20 | −0.49 | 0.01 | 0.47 |
Sudden death | — | — | 1.34 | 1.34 | — | 1.08 | 1.17 | −1.21 | 1.90 | 0.45 |
Ventricular tachycardia | — | — | −0.90 | 0.59 | — | — | — | — | −0.61 | — |
Cardio-respiratory arrest | — | — | −0.54 | −0.87 | — | −1.00 | — | −0.74 | −1.59 | — |
Ventricular fibrillation | — | — | −1.32 | −0.90 | — | — | — | — | — | — |